Curex Tirzepatide Review: Cost, an Allergy-Company Pivot & Honest Verdict (2026)

Curex: $199/month for tirzepatide, with a genuine LegitScript certification and a named operating entity — Curex, Inc. — with two real offices in Miami and NYC. Every fact here comes from the company's own published program.

What Curex is

Curex (Curex, Inc.) is to be LegitScript certified, with offices in Miami, FL confirmed and a second office in NYC. Its primary business, is actually allergy immunotherapy — GLP-1 is a newer vertical for the company, not its founding focus.

What Curex costs

Compounded tirzepatide runs $199/month in the oral dissolving tablet format, and semaglutide is at $149/month. Curex offers both injectable and oral dissolving tablet formats — a real format choice most competitors don't offer — with no membership fee ever.

Explicitly compounded-only, stated plainly

Curex's own site states directly, "We don't prescribe Ozempic, Wegovy, Zepbound, or Mounjaro" — an unusually blunt, plain-language disclosure of its compounded-only model, rather than the vaguer language some competitors use.

State coverage gaps

Curex is not available in Alaska, Arkansas, Connecticut, Hawaii, Massachusetts, New Mexico, or Missouri — confirm your state is covered before starting an intake.

The brand-vs-compounded question

Curex dispenses compounded tirzepatide only, and says so explicitly. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Curex's real strengths: LegitScript certification, a named entity with two real offices, both injectable and oral formats, an explicit, plain-language statement that it doesn't dispense brand medications, and no membership fee ever and third-party lab testing via FDA/DEA-certified labs. The trade-offs: it's not available in 7 states, it's compounded only, and its primary business is allergy immunotherapy, with GLP-1 as a newer, less-established vertical for the company. As with any GLP-1 program, confirm your state's coverage before starting the intake; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Curex's named entity, real offices, and unusually plain-language compounded-only disclosure are genuine positives, but weigh its GLP-1 vertical as newer relative to its allergy-immunotherapy core business, and confirm your state is among those covered. If GLP-1 focus and a longer track record in this specific category matter more to you, compare it against Cielo or CoreAge Rx. For a Shopify-based provider with similarly plain-spoken pricing but a state-coverage claim worth double-checking, see DoctorAdam. See our best tirzepatide providers ranking for the full field.